搜索临床试验以:Open-label AZD2014
总计2579个结果
-
Samsung Medical Center撤销
-
Massachusetts General HospitalUnited States Department of Defense; AstraZeneca完全的
-
Samsung Medical CenterAstraZeneca终止
-
Massachusetts General HospitalNational Cancer Institute (NCI); AstraZeneca主动,不招人
-
Royal Marsden NHS Foundation TrustAstraZeneca; Institute of Cancer Research, United Kingdom完全的
-
AstraZeneca撤销核心:复发或难治性弥漫性大 B 细胞淋巴瘤 | 模块 1:非 GCB 弥漫性大 B 细胞淋巴瘤
-
Canadian Cancer Trials GroupAstraZeneca完全的
-
Cambridge University Hospitals NHS Foundation TrustAstraZeneca完全的
-
Queen Mary University of LondonAstraZeneca; Cancer Research UK未知鳞状细胞肺癌 | 三阴性乳腺癌 | 具有 KRAS 突变的非鳞状细胞肺癌 | 具有野生型 KRAS 的非鳞状细胞肺癌英国
-
AstraZenecaNational Institutes of Health (NIH); Eolas Therapeutics INC.完全的
-
Northumbria Healthcare NHS Foundation Trust招聘中
-
AstraZenecaSCRI Development Innovations, LLC完全的
-
Ain Shams UniversityTrudell Medical International招聘中
-
National Cancer Institute (NCI)终止大肠癌 | 转移性结肠腺癌 | 转移性直肠腺癌 | III 期结肠癌 AJCC v8 | III 期直肠癌 AJCC v8 | IIIA 期结肠癌 AJCC v8 | IIIA 期直肠癌 AJCC v8 | IIIB 期结肠癌 AJCC v8 | IIIB 期直肠癌 AJCC v8 | IIIC 期结肠癌 AJCC v8 | IIIC 期直肠癌 AJCC v8 | IV 期结肠癌 AJCC v8 | IV 期直肠癌 AJCC v8 | IVA 期结肠癌 AJCC v8 | IVA 期直肠癌 AJCC v8 | IVB 期结肠癌 AJCC v8 | IVB 期直肠癌 AJCC v8 | IVC 期结肠癌 AJCC v8 | IVC 期直肠癌 AJCC v8 | 不可切除的结肠腺癌 | 不可切除的...美国
-
Queen Mary University of LondonAstraZeneca; Cancer Research UK终止
-
National Institute of Allergy and Infectious Diseases...完全的
-
National Cancer Institute (NCI)终止难治性恶性实体瘤 | 复发性恶性实体瘤 | 转移性恶性实体瘤 | 不可切除的实体瘤 | 复发性肺小细胞癌 | IIIA 期肺癌小细胞癌 AJCC v7 | IIIB 期肺癌小细胞癌 AJCC v7 | IV 期肺小细胞癌 AJCC v7 | III 期肺小细胞癌,美国癌症联合委员会 (AJCC) v7美国
-
Massachusetts General HospitalNational Center for Complementary and Integrative Health (NCCIH); Harvard University完全的